Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study

PloS One
Lei HeFumin Feng

Abstract

Anti-tuberculosis (anti-TB) drug-induced liver injury (ADLI) is one of the most common adverse effects associated with TB treatment. Cytochrome P450 (CYP) 1A1 and glutathione S-transferase (GST) P1 are important phase I/II metabolizing enzymes involved in drug metabolism and detoxification. Genetic polymorphism and CpG island methylation have been reported as factors influencing the expression of CYP1A1 and GSTP1. This study aimed to determine the potential relationships of CYP1A1 and GSTP1 polymorphisms and CpG island methylation with ADLI risk. This was a population-based one-to-one matched case-control study. The subjects were patients with TB receiving treatment in China from December 2010 to June 2013. In total, 127 patients with TB and ADLI (case group) and 127 patients with TB but without liver injury (control group) were included in this study. Subjects were matched in terms of sex, age, and therapeutic regimen. The general condition of each patient was assessed using questionnaires. The CYP1A1 MspI and GSTP1 Ile105Val polymorphisms as well as methylation status were detected by polymerase chain reaction (PCR)-restriction fragment length polymorphism and the methylation-specific PCR method. We found no significant diffe...Continue Reading

References

Jun 23, 2001·Oncogene·M R RountreeS B Baylin
May 19, 2005·Molecular and Cellular Biology·Kristoffer PadjenUrsula Storb
Dec 13, 2005·Nature Clinical Practice. Oncology·Lewis R Silverman, Ghulam J Mufti
Dec 13, 2005·Nature Clinical Practice. Oncology·Steven D Gore
Dec 16, 2005·Molecular and Cellular Biology·Guillaume J P FilionPierre-Antoine Defossez
Sep 26, 2007·Human Molecular Genetics·Manel Esteller
Oct 9, 2007·Toxicology and Applied Pharmacology·V M KovalenkoI P Pogribny
Apr 10, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Virginia LeiroArturo González-Quintela
May 9, 2008·American Journal of Physiology. Cell Physiology·Behnam SaberiDerick Han
May 23, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Leonor Varela-LemaCamille C Ragin
Jun 11, 2008·British Journal of Cancer·L Lopez-Serra, M Esteller
Nov 26, 2008·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·François DurandJacques Belghiti
Dec 19, 2009·Handbook of Experimental Pharmacology·Derick HanNeil Kaplowitz
Aug 26, 2011·Cell Biology International·Zhiqin LiShenglei Li
Oct 19, 2011·Environmental Toxicology and Pharmacology·Bing ZhangFumin Feng
Mar 13, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naoshi NishidaAjay Goel
Apr 18, 2012·Clinical and Experimental Pharmacology & Physiology·Hui-Ru AnYan Liang
Jun 7, 2012·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·Charlotte SchutzGraeme Meintjes
Dec 13, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N TangG Zhou
Apr 27, 2013·Environmental Toxicology and Pharmacology·Lihong ShenFumin Feng
May 18, 2013·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Deepika ShuklaShashwat Mishra
Jul 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Hesham Mahmoud SaeedMaha Arafaha
Nov 26, 2013·Lancet·Alimuddin Zumla Baroness Masham of Ilton
Mar 19, 2014·Biomarker Research·Way-Champ Mah, Caroline Gl Lee

❮ Previous
Next ❯

Citations

Oct 3, 2015·Environmental Science and Pollution Research International·Lan YiDexin Ding
Apr 12, 2016·Clinical Pharmacology and Therapeutics·P FiselM Schwab
Nov 18, 2018·Redox Report : Communications in Free Radical Research·Shangfu XuLili Ji
Jul 16, 2019·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Dongying LiBaitang Ning
Jun 28, 2019·Clinical Pharmacology and Therapeutics·Cong HuaiShengying Qin
Apr 23, 2020·International Journal of Oncology·Jian CuiLan Yi
Feb 23, 2020·Frontiers in Pharmacology·Siyu FuTaoyou Zhou

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.